Ligand-induced receptor oligomerization is a widely accepted mechanism for activation of cell-surface receptors. We investigated ligand-receptor interactions in the glial cell-line derived neurotrophic factor (GDNF) receptor complex, formed by the c-Ret receptor tyrosine kinase and the glycosylphosphatidylinositol (GPI)-anchored subunit GDNF family receptor alpha-1 (GFRα1). As only GFRα1 can bind GDNF directly, receptor complex formation is thought to be initiated by GDNF binding to this receptor. Here we identify an interface in GDNF formed by exposed acidic and hydrophobic residues that is critical for binding to GFRα1. Unexpectedly, several GDNF mutants deficient in GFRα1 binding retained the ability to bind and activate c-Ret at normal levels. Although impaired in binding GFRα1 efficiently, these mutants still required GFRα1 for c-Ret activation. These findings support a role for c-Ret in ligand binding and indicate that GDNF does not initiate receptor complex formation, but rather interacts with a pre-assembled GFRα1-c-Ret complex.
Introduction
Most biological processes are governed by specific protein-protein interactions. When growth factors bind to their receptors, an extensive surface becomes buried in the binding interface, typically involving 10-30 amino acid residues from each protein (De Vos et al., 1992; Banner et al., 1993; Wiesmann et al., 1997) . However, in the few cases investigated directly, only a small and complementary set of contact residues maintains binding affinity between ligand and receptor. In the complex formed by human growth hormone and its receptor, for example, the functional epitope is formed by a central hydrophobic region surrounded by hydrophilic residues of lower importance (De Vos et al., 1992; Clackson and Wells, 1995) . Mutagenesis studies have shown that fewer than half of the residues buried in the binding interface of this complex contribute~90% of the total binding energy (Clackson and Wells, 1995) . Similarly, in the neurotrophins, three basic residues provide the critical binding determinants for interaction with their p75 receptor (Ibáñez et al., 1992; Rydén et al., 1995) . These and other examples indicate that functional studies of binding surfaces are required for a complete understanding of protein-protein interactions, in order to determine to what extent different exposed residues contribute to the overall binding energy of a complex.
Glial cell-line derived neurotrophic factor (GDNF) is a distant member of the transforming growth factor-β (TGF-β) superfamily that promotes survival and differentiation of subpopulations of central and peripheral neurons, including several groups of neurons that are compromised in many neurodegenerative diseases (Lapchak, 1996; Unsicker, 1996) . GDNF is also an inducer and branching factor of ureteric buds during kidney development (Sariola and Sainio, 1997) . The neurotrophic and morphogenic activities of GDNF are mediated by its interaction with a multicomponent receptor complex formed by the c-Ret receptor tyrosine kinase (Durbec et al., 1996; Trupp et al., 1996; Vega et al., 1996; Worby et al., 1996) and a glycosylphosphatidylinositol (GPI)-anchored 'accessory' receptor, GDNF family receptor alpha-1 (GFRα1), which is required for ligand binding (Jing et al., 1996; Treanor et al., 1996) . Complex formation is believed to result in c-Ret dimerization and activation of the c-Ret tyrosine kinase. The current model of GDNF signalling proposes a stringent division of labour between GFRα1 and c-Ret receptors, in which the latter delivers the intracellular signal but cannot bind ligand on its own, whereas the former binds ligand but is thought not to signal in the absence of c-Ret. Three close mammalian homologues of GDNF have been identified, all of which utilize c-Ret as the signalling receptor component with the aid of different members (GFRα1-4) of the GFRα family of GPI-linked accessory receptors (Buj-Bello et al., 1997; Klein et al., 1997; Baloh et al., 1998; Enokido et al., 1998; Trupp et al., 1998) . GFRα receptors have been shown to provide some degree of ligand specificity, although cross-talk between the different receptors is also possible (Ibáñez, 1998) .
c-Ret is not alone among receptor tyrosine kinases in its dependence on an accessory receptor component, although it is the first known to utilize a GPI-anchored partner (Lindsay and Yancopoulos, 1996) . It remains unclear as to how accessory components facilitate ligand binding to and dimerization of signalling components. One possibility is that the ligand and the accessory receptor present a combined surface for binding to the signalling components; alternatively, binding of ligand to the accessory component may change the conformation of either molecule allowing it to bind and activate the signalling receptor. Finally, it is also possible that accessory and signalling components form a pre-associated complex to which ligands bind. Although it has been shown that c-Ret, GFRα1 and GDNF can form a complex (Treanor et al., 1996) , the interactions required for its assembly and stabilization remain to be defined. Initial studies led to the suggestion that c-Ret may not contribute to the interaction of GDNF with the receptor complex (Jing et al., 1996) . However, GDNF can be chemically crosslinked to c-Ret with high efficiency (Trupp et al., 1996) , indicating that the two molecules contact each other in the complex. Moreover, c-Ret has been shown to enhance the binding of GDNF to other non-preferred members of the GFRα family, such as GFRα2 and GFRα3 (Sanicola et al., 1997; Trupp et al., 1998) . Together, these observations suggest that the interaction between GDNF and c-Ret may play an important role in the assembly and stability of functional receptor complexes. Finally, it has also been shown that GFRα receptors can, to some extent, interact with c-Ret in the absence of ligands (Sanicola et al., 1997; Trupp et al., 1998) , suggesting that GDNF could also function by stabilizing pre-formed complexes of GFRα1 and c-Ret.
The GDNF-GFRα1-c-Ret complex provides an attractive system in which to investigate protein-protein interactions involved in the assembly of multi-subunit receptor complexes. In this work, we investigated structurefunction relationships in GDNF using alanine scanning mutagenesis of surface-exposed amino acid residues. Using cell lines expressing a defined complement of receptor components, we probed the ability of different GDNF mutants to bind GFRα1 and to activate c-Ret. Our results define a hot spot in GDNF for binding to the GFRα1 receptor, and suggest a new model for the assembly of the GDNF receptor complex.
Results

Prominent features of the GDNF molecular surface
The three-dimensional structure of the GDNF monomer is characterized by two long fingers formed by pairs of anti-parallel β-strands connected by loops, and a helical region at the opposite end (Eigenbrot and Gerber, 1997) . Both protomers associate in a tail-to-head orientation to form an elongated, cigar-shaped dimer with the two helices flanking a cysteine-knot motif at the centre of the structure ( Figure 1A ). The crystal structure of GDNF reflects its structural similarities to members of the TGF-β superfamily, originally predicted from the conserved pattern of cysteine residues in the primary sequences of these two factors (Lin et al., 1993) . Negatively, positively and uncharged regions are well segregated in the GDNF dimer ( Figure 1B) . A continuous belt of net positive charge forms across the middle of the dimer, including Lys81, Lys84, Arg88, Arg90 and Arg91 from the exposed surface of the α-helix, Lys37 and Arg39 from the N-terminal region of the first finger, and Lys129 and Arg130 from the second protomer ( Figure 1B) . Negatively charged residues, including Asp52, Glu58, Glu61 and Glu62 from the first finger and Asp109, Asp110, Asp115 and Asp116 from the second finger, cluster at the end of the elongated GDNF protomer forming a patch of negative electrostatic potential ( Figure 1B) . A symmetric patch is formed at the opposite end by the corresponding residues from the 5902 second protomer. A plot of the solvent accessibility of the different amino acid residues in GDNF reveals several highly exposed hydrophobic residues including a prominent patch in the tip of the second finger formed by Leu114, Leu116, Leu118, Val119, Tyr120 and Ile122 ( Figure 1C ). The first 36 residues in the N-terminus, as well as four residues in a loop connecting the α-helix with the second finger, could not be resolved in the crystal structure and probably represent highly flexible regions in the molecule.
Site-directed mutagenesis of solvent-accessible residues in GDNF We targeted different features of the GDNF molecular surface using site-directed mutagenesis. Highly exposed, positively charged (blue bars, Figure 1C ), negatively charged (red bars, Figure 1C ) and hydrophobic (green bars, Figure 1C ) residues were mutated into alanine, either individually or in combinations of two to four residues. Alanine is best suited to the scanning approach because it can accommodate most elements of the secondary structure of proteins, so it conveniently combines small size with minimal structural distortion. Here, these mutants will be referred to by the wild-type residue(s) as singleletter code, followed by their position in the primary sequence of mature rat GDNF, followed by the replacing residue(s), in most cases A for alanine. The cysteine residue at position 101 involved in the disulfide bridge that connects the two protomers was also changed into Ala. The six residues in the flexible loop connecting the α-helix with the second finger (RLTSDK, grey bars, Figure 1C ) were replaced by topologically equivalent residues from TGF-β2 (TINPEA). Finally, we also generated a deletion of the N-terminal extension of GDNF, which, interestingly, is a unique feature of this molecule and is not present in the other members of the GDNF family.
Mutant GDNF proteins were produced in the conditioned medium of transiently transfected COS cells and quantified by Western blotting using different specific antipeptide antibodies and purified recombinant GDNF as standard. Two mutant proteins were purified from COS cell-conditioned medium for further analyses as indicated below; all other mutants were assayed directly from concentrated conditioned medium. Medium from mocktransfected cells had negligible effects on either binding or c-Ret phosphorylation. Most of the mutants were produced at levels comparable with wild-type, indicating that they undergo folding without major problems. The main exceptions were the triple mutant DDD108AAA, the double mutant DD115AA and the D115A mutation, which could not be detected in supernatants of transfected COS cells. Individual mutations of D109, D110 and D116 were, however, well tolerated. Binding to the GFRα1 receptor was assessed by the ability of the mutants to displace radiolabelled GDNF from GFRα1-binding sites in a MG87 fibroblast cell line stably transfected with a GFRα1 cDNA (herein called M23 cells). M23 cells do not express detectable levels of c-Ret or any GFRα receptor other than GFRα1. Receptor binding was quantified by direct measurement of radiolabelled GDNF bound to cells or by subsequent cross-linking, SDS-PAGE and phosphorimaging quantification of affinity-labelled receptor bands. The latter technique gave a relatively low non- Negative potential is shown in red, positive in blue and neutral in white. This image was generated using the program GRASP (Nicholls et al., 1991) . (C) Solvent accessibility plot of GDNF residues visible in the X-ray crystal structure (Eigenbrot and Gerber, 1997) , calculated with NACCESS (Hubbard and Thornton, 1993) . This program calculates the atomic accessible surface defined by rolling a probe of 1.40 Å around a van der Waals surface. Coloured bars (blue, basic; red, acidic; green, hydrophobic; brown, cysteine) indicate residues targeted by site-directed mutagenesis. In one of the mutant molecules, hatched residues at positions 91-96 (RLTSDK) were replaced by the corresponding residues in TGF-β2 (TINPEA). Elements of the secondary structure are indicated below. Arrows, β-strands; spring, turn; cylinder, α-helix. specific background signal (Ͻ5%), at the same time allowing us to distinguish the contribution of either the GFRα1 or c-Ret receptor subunits to GDNF binding (see below), and this was the method used in most assays. In all experiments, wild-type GDNF produced and quantified under the same conditions was used as an internal standard, and all binding data are expressed as percentage relative to wild-type. Since the concentration of radiolabelled GDNF used as a tracer was close to the K d of binding (i.e. 4 ϫ 10 -10 M), the values reported are good estimates of the relative binding affinity of the mutant molecules to the GFRα1 receptor. Figure 2 shows representative examples of displacement binding assays analysed by cross-linking, all the results are summarized in Table I .
Although positively charged residues constitute a prominent feature of the GDNF molecular surface ( Figure 1B ), they are dispensable for GDNF binding to the GFRα1 receptor (Table I ). In particular, although the quadruple mutation K81A ϩ K84A ϩ R88A ϩ R90A removes almost all the positive charges from the centre of the dimer, this molecule has almost equal binding affinity to wild-type GDNF ( Figure 2A and Table I ). Several negatively charged residues, however, are critical for GFRα1 binding, including D52, E61 and E62 in finger 1, and D116 in finger 2 (Table I) . These residues contribute most of the negative electrostatic potential located at the two symmetric ends of the elongated GDNF dimer ( Figure 1B) , suggesting that the distal ends of the two fingers in GDNF are points of contact with GFRα1 receptors. This notion is strengthened by our analyses of exposed hydrophobic residues in this region. Four hydrophobic residues appear to be crucial for GDNF binding to GFRα1, all are located at the distal ends of fingers 1 and 2, including I64 in finger 1, and L114, Y120 and I122 in finger 2 ( Figure 2B and Table I ). Although less important, mutation of L118 also had an effect on GFRα1 binding (Table I) . Together, these data indicate that GFRα1 binds to GDNF by contacting exposed negatively charged and hydrophobic residues in the distal ends of fingers 1 and 2.
Replacement of six residues in the central loop connecting the α-helix with the second finger by equivalent residues from TGF-β2 did not have any major effect on GDNF binding to GFRα1 (Table I) . This is in agreement with the GFRα1-binding sites being localized at the two ends of the GDNF dimer. In contrast, mutation of C101, involved in an interprotomer disulfide bridge, or deletion of the N-terminal extension of GDNF, reduced binding to GFRα1 by~20-fold (Table I) .
Discrepancy between GFRα1 binding and c-Ret phosphorylation
The ability of wild-type and mutant GDNF molecules to recruit the c-Ret receptor tyrosine kinase to the receptor complex was determined by assessing c-Ret tyrosine phosphorylation in fibroblast cells co-expressing GFRα1 and c-Ret (M23-Ret). Figure 3 shows representative examples of c-Ret phosphorylation assays; all the results are summarized in Table I . Because GDNF cannot bind or activate c-Ret in the absence of GFRα receptors, we expected a good correlation between the ability of GDNF mutants to bind GFRα1 and their ability to induce c-Ret tyrosine phosphorylation. In agreement with this, mutation of the acidic residues in finger 1, which disrupted binding to GFRα1, i.e. D52A and E61A, as well as mutation of the dimerizing Cys101, resulted in a pronounced reduction (Ͼ10-and 4-fold, respectively) in ligand-stimulated c-Ret phosphorylation ( Figure 3A and Table I) . Surprisingly, however, none of the residues located in finger 2 that are 5904 critical for GFRα1 binding appears to be necessary for stimulation of c-Ret phosphorylation ( Figure 3B and Table I ). These include negatively charged residues, such as D116, as well as hydrophobic residues, such as L114 and Y120 ( Figure 3B ), whose mutation into Ala significantly reduced binding to GFRα1. Dose-response analyses of c-Ret tyrosine phosphorylation induced by different GDNF molecules indicated a fully normal response of L114A, D116A and Y120A mutants at a broad range of concentrations ( Figure 3B ). The same was true for the GDNF mutant with a deletion in the N-terminus, which stimulated c-Ret phosphorylation at wild-type levels, despite having 20-fold lower affinity for GFRα1 (Table I) . However, we did not find any GDNF mutant that was capable of binding GFRα1 but unable to induce c-Ret phosphorylation (Table I) .
The ability of some of the GDNF mutants deficient in GFRα1 binding to stimulate c-Ret phosphorylation at normal levels indicated that they are capable of interacting with c-Ret or with a protein complex containing this receptor. We, therefore, tested the ability of several of these mutants to displace radiolabelled GDNF from 
Underlining highlights major effects of the mutations. Binding is expressed as percentage of wild-type using the equation: 100ϫ (mutant IC 50 /wild-type IC 50 ). The numbers shown are averages of at least three independent experiments each from duplicate or quadruplicate wells. All phosphorylation assays were performed in dose-responses similar to those shown in Figure 3B and quantified using ImageQuant software (Materials and methods). The results shown are representative of two or three independent experiments.
M23-Ret cells co-expressing GFRα1 and c-Ret receptors. These experiments indicated that L114A, D116A and Y120A mutants are still unable to displace iodinated GDNF from GFRα1-binding sites on M23-Ret cells (Figure 4A and B; data not shown). However, the three mutants are capable of displacing all radiolabelled GDNF from c-Ret with a dose-response profile comparable with wild-type (Figure 4A and C; data not shown). These data indicate that although they show diminished binding to GFRα1, these GDNF mutants still retain almost wild-type affinity for c-Ret, which is in agreement with their ability to stimulate c-Ret phosphorylation at normal levels. Together, our results show that acidic and hydrophobic residues in fingers 1 and 2 of GDNF are required for binding to the GFRα1 receptor, whereas only residues in finger 1 appear to be necessary for binding to and activation of c-Ret. are all able to stimulate c-Ret phosphorylation at normal levels despite their inability to bind to GFRα1 efficiently. All phosphorylation assays were repeated at least three times with identical results.
GDNF mutants deficient in GFRα1 binding still require GFRα1 for c-Ret activation
Are these GDNF mutants able to interact with c-Ret directly, without the aid of GFRα1 receptors? To address this point, we purified the Y120A mutant from the conditioned medium of transiently transfected COS cells and tested its ability to stimulate c-Ret phosphorylation in M23-Ret cells that had previously been treated with phosphatidylinositol phospholipase C (PIPLC), which removes all GPI-anchored proteins from the cell membrane, including GFRα receptors. Figure 5A shows that pretreatment of M23-Ret cells with PIPLC abolishes the ability of both wild-type and Y120A mutant GDNF to stimulate c-Ret phosphorylation. Thus, although the Y120A mutant cannot bind to GFRα1 directly, it still requires GFRα1 receptors on the cell membrane to stimulate c-Ret phosphorylation in M23-Ret cells. Finally, we investigated the activities of wild-type and Y120A mutant in cells expressing only c-Ret (MG87-Ret). The absence of GFRα receptors in these cells results in a slight increase of basal ligand-independent c-Ret phosphorylation compared with M23-Ret cells, as reported previously (Trupp et al., 1998) . In agreement with the PIPLC experiment, neither wild-type GDNF nor the Y120A mutant are able to stimulate c-Ret phosphorylation above background levels in these cells ( Figure 5B ), corroborating the requirement of GFRα1 for c-Ret activation by the Y120A mutant. This result also demonstrates that the stimulation of c-Ret phosphorylation elicited by the Y120A mutant in M23-Ret cells could not have been mediated through interaction with low amounts of GFRα receptors endogenously expressed by the parental MG87 line, if such receptors exist.
As reported previously by others (Jing et al., 1996; Treanor et al., 1996; Yu et al., 1998) , soluble GFRα1 provided in trans reinstates the ability of wild-type GDNF to stimulate c-Ret phosphorylation in cells lacking endogenous GFRα1 receptors ( Figure 5B, left) . The Y120A mutant is, however, much less efficient at stimulating c-Ret phosphorylation using soluble GFRα1, only a small increase over background levels could be seen ( Figure 5B , left). In a parallel experiment performed in M23-Ret cells, however, the Y120A mutant was as efficacious as wild-type GDNF at stimulating c-Ret phosphorylation ( Figure 5B, right) . Thus, the impaired ability of the Y120A mutant to bind to GFRα1 prevents it from utilizing soluble GFRα1 receptors to stimulate c-Ret activation in c-Retonly cells, suggesting that, in contrast to membrane-bound receptors, soluble GFRα1 molecules first form a complex with GDNF, and this complex subsequently binds to and activates membrane-bound c-Ret.
Discussion
In this study we identified the structural elements in the molecular surface of GDNF responsible for its interaction 5906 with the GFRα1 receptor. Several features of this surface were investigated using site-directed mutagenesis, including exposed positively and negatively charged residues, exposed hydrophobic residues, a 36-residue N-terminal extension and a loop region in the middle of the molecule. This analysis revealed a set of eight residues, four negatively charged (Asp52, Glu61, Glu62, Asp116) and four hydrophobic (Ile64, Leu114, Tyr120, Ile122), that form a hot spot for GDNF binding to the GFRα1 receptor ( Figure 6A and B) . Individual mutation of any of these residues into Ala had a major effect on the binding affinity of GDNF to GFRα1, indicating that each of them makes an important contribution to the binding energy of the GDNF-GFRα1 complex. Similar to other ligand-receptor complexes, many more residues are probably buried in the GDNF-GFRα1 binding interface. These may include neighbouring residues whose individual mutation into Ala showed a smaller effect on binding, such as Glu58, Lys60 and Leu118, and residues contributing low binding energy, which is revealed only in the context of other mutations. Together, these residues define a surface for binding to GFRα1 localized at the distal end of the elongated GDNF molecule ( Figure 6C ). Owing to the 2-fold symmetry of the GDNF dimer, identical binding surfaces are formed on both sides of the molecule, each composed of structural elements from a single protomer ( Figure 6A and B) . Indirect evidence supports a 1:2 stoichiometry for the GDNF-GFRα1 complex (Jing et al., 1996) , so it is easy to envision how two molecules of GFRα1 may each associate with the GDNF dimer through these two symmetrically related sites. We, therefore, propose that GDNF binds with its 2-fold symmetry axis perpendicular to the cell membrane (orientation shown in Figure 6A ) to a were stimulated with the indicated purified ligands at 100 ng/ml. Where indicated, purified soluble GFRα1-Fc fusion protein (R&D Systems) was also added at 300 ng/ml, corresponding to~1:1 GDNF:GFRα1-Fc molar ratio. These experiments were repeated two or three times with identical results.
GFRα1 dimer that clamps the two GDNF protomers through symmetrically related surfaces located in the distal part of the molecule ( Figure 6A and B) .
Deletion of the N-terminal extension of GDNF also affected binding to GFRα1, indicating that some of the residues in this domain contribute to the GDNF-GFRα1 interaction. In contrast, the effect of the C101A mutation on both GFRα1 binding and c-Ret activation possibly involves conformational changes and/or partial destabilization of the GDNF dimer. Interestingly, a TGF-β1 mutant with the corresponding dimerizing Cys replaced by Ser also showed reduced, but still detectable, biological activity (Amatayakul-Chantler et al., 1994) . Several of the positions identified at the site of GDNF binding to the GFRα1 receptor correspond to variable residues in other members of the GDNF family, including Glu62, Asp116, Leu118 and Ile122 (Table II) , suggesting that these, as well as other neighbouring variable residues, could represent determinants of receptor binding specificity in this group of molecules.
Unexpectedly, binding to GFRα1 and activation of the c-Ret receptor tyrosine kinase could be dissociated in several of the GDNF mutants generated. The Y120A mutant, for example, is not able to utilize GFRα1 or c-Ret if these are expressed independently, but displaces the 5907 binding of iodinated GDNF to c-Ret and stimulates normal c-Ret activation in cells that co-express the two receptors. This finding has at least two implications for the mode of action of GDNF and the way in which active GDNF receptor complexes are assembled.
In the first place, c-Ret possibly plays a much more important role in ligand binding than thought previously. This notion is also supported by cross-linking experiments indicating a direct association between c-Ret and GDNF, and by the functional promiscuity displayed by GDNF family ligands in the presence of c-Ret. Thus, for example, although GDNF does not normally bind to GFRα3, it can be cross-linked to this receptor in cells co-expressing c-Ret (Trupp et al., 1998) . Moreover, the GDNF homologue artemin (ART) was recently found to be capable of stimulating c-Ret-dependent signalling in cells coexpressing GFRα1 and c-Ret, despite being unable to bind to isolated GFRα1 (Baloh et al., 1998) . Although no dose-response analysis was made in that study, the behaviour of ART is not unlike that of the Y120A mutant, which can activate the c-Ret receptor normally despite its inability to displace GDNF binding from GFRα1 in GFRα1-only cells. The binding energy of the c-Ret-GDNF interaction is clearly not sufficient for c-Ret to bind ligand on its own, so it is likely that each component in the complex is interacting with all other subunits through multiple contacts.
The second implication of our findings relates to the nature of the GDNF receptors present in cells coexpressing GFRα1 and c-Ret. The fact that the Y120A mutant can bind and activate c-Ret as efficiently as wildtype GDNF, but still necessitates the presence of the GFRα1 receptor in the cell membrane, suggests that this mutant interacts with a binding site formed by a preassociated GFRα1-c-Ret complex. There is evidence in the literature supporting the capacity of GFRα and c-Ret receptors to associate with each other in the absence of ligand. Using co-immunoprecipitation experiments, Treanor et al. (1996) and Klein et al. (1997) have shown that GFRα1 and GFRα2 can associate with c-Ret in the absence of ligand. The amount of this complex that is recovered could be increased significantly by the addition of GDNF or neurturin (NTN), respectively, suggesting that the ligand stabilizes the association of GFRα receptors with c-Ret. In another study, Sanicola et al. (1997) independently isolated GFRα1 by utilizing an expression cloning strategy in which the probe was a soluble c-RetIg fusion protein. A fixation step was found to be necessary for detection of GFRα1 by the c-Ret fusion, indicating that the interaction between the two molecules is of relatively low affinity (Sanicola et al., 1997) . Finally, we have shown previously that co-expression of GFRα1 and c-Ret in COS cells diminishes constitutive c-Ret phosphorylation in a dose-dependent manner (Trupp et al., 1998) , suggesting a ligand-independent interaction between GFRα1 and c-Ret in the cell membrane. Based on this evidence and our present results, we propose the existence of at least two distinct binding sites for GDNF in cells co-expressing GFRα1 and c-Ret receptors ( Figure 6D ). The first site is formed exclusively by GFRα1 subunits. GDNF binding to this site requires acidic and hydrophobic residues in fingers 1 and 2, as well as residues in the N-terminus of GDNF. Several of the mutants Figure 1A , i.e. perpendicular to a vertical 2-fold symmetry axis, with critical residues for GFRα1 binding labelled and highlighted in colour. Red, Glu and Asp; magenta, Tyr; light brown, Ile and Leu. (B) View rotated 90°from (A) to look along the 2-fold axis of the dimer. Note that most residues in the GFRα1-binding site are exposed in this view. (C) Van der Waals surface model of GDNF viewed from one of its ends, with residues in the GFRα1-binding site highlighted in colour. The two GDNF protomers are in white and green, respectively. (D) Two distinct binding sites for GDNF. Site I consists exclusively of GFRα1 receptors. GDNF binding to this site requires negatively charged and hydrophobic residues in fingers 1 and 2 and in the N-terminus. Signalling downstream of this complex appears to include activation of Src-like kinases in membrane rafts (Trupp et al., 1999) . Site II consists of a pre-associated GFRα1-c-Ret complex. The actual stoichiometry of this complex, i.e. heterodimer versus heterotetramer, is unknown. GDNF binding to this site requires negatively charged residues in finger 1, but not in finger 2 or in the N-terminus. Signalling downstream of this complex includes activation of the Ras, PI3K, PLCγ and other pathways (Trupp et al., 1999) . generated in this study, such as Y120A, cannot bind to this site efficiently. The second site consists of a preassociated GFRα1-c-Ret complex. GDNF binding to this site requires acidic residues in finger 1, but not finger 2, of GDNF. Mutations in finger 2 residues do not affect the interaction of GDNF with this second site and allow c-Ret tyrosine phosphorylation at normal levels. The apparent inability of the Y120A mutant to displace iodinated GDNF from GFRα1 in M23-Ret cells indicates that only a relatively small fraction of GFRα1 receptors are preassociated with c-Ret in these cells. This model could also explain the reported cases of promiscuity in the interaction of GDNF family members with GFRα receptors. Thus, for example, NTN promotes the survival of dopaminergic neurons, which express GFRα1 but not the cognate NTN receptor GFRα2 (Horger et al., 1998) , and is also able to induce c-Ret phosphorylation in fibroblasts expressing GFRα1 (Baloh et al., 1997) . In contrast, survival of submandibular ganglion neurons by NTN is unaffected by elimination of GFRα1 (Horger et al., 1998) , as this activity of NTN is known to be mediated by GFRα2 (Rossi et al., 1999) . In addition, ART has been shown to elicit transcriptional responses in transfected cells expressing c-Ret and GFRα1 in the absence of GFRα3, its preferred receptor (Baloh et al., 1998) . Whereas neither NTN nor ART are able to bind to GFRα1 with high affinity, it is possible that, like some of the GDNF mutants described here, these factors are capable of interacting with a pre-formed GFRα1-c-Ret complex.
Current models of c-Ret activation propose that GDNF first binds to GFRα1 and that c-Ret is subsequently recruited to the GDNF-GFRα1 complex (Jing et al., 1996; Treanor et al., 1996) . The fact that several GDNF mutants deficient in GFRα1 binding are still able to activate c-Ret normally suggests that the current model cannot be the predominant mechanism for c-Ret activation, and that the majority of c-Ret signalling sites may consist of a preassociated GFRα1-c-Ret complex. Interestingly, our data indicate that the Y120A mutant cannot utilize soluble GFRα1 for activation of c-Ret as efficiently as wild-type GDNF. Whereas soluble GFRα1 has access to a threedimensional space, membrane-anchored GFRα1 is restricted to the plane of the cell membrane. A higher concentration of soluble GFRα1 receptors might therefore be required to allow c-Ret activation by the Y120A mutant.
Finally, we would like to draw attention to the possibility that the two GDNF-binding sites mentioned above may, in addition, have different functional capabilities. Whereas signalling by the GFRα1-c-Ret complex utilizes the well-known Ras, phosphatidyl inositol-3 kinase (PI3K), phospholipase Cγ (PLCγ) and probably other pathways characteristic of receptor tyrosine kinases, we have recently demonstrated the existence of an alternative mechanism of GDNF signalling mediated by GFRα1 receptors acting in a cell-autonomous manner independently of c-Ret (Trupp et al., 1999) . This pathway involves the association of GFRα1 with members of the Src family of cytoplasmic tyrosine kinases, Src-like kinase activation and phosphorylation of downstream substrates (Trupp et al., 1999) . A similar signalling mechanism has also been described for other GPI-anchored receptors and, like many of those receptors, GFRα1 is present in detergent-insoluble membrane rafts that are also rich in Src-like kinases (C.F.Ibáñez, unpublished observations). Whether GFRα1 is able to signal on its own or in association with other, as yet unknown, transmembrane proteins is still unclear.
In conclusion, we have identified structural elements mediating the interaction of GDNF with the GFRα1 receptor and have generated GDNF mutants that have a reduced capacity to bind to this receptor, but retain the ability to induce normal c-Ret phosphorylation. Because these mutants still require GFRα1 to activate c-Ret, we propose the existence of two distinct binding sites for GDNF, one formed by GFRα1 alone and another formed by a pre-associated GFRα1-c-Ret complex. These two sites may have different signalling capabilities which can now be dissected with the help of the GDNF mutants described in this study.
Protein production, purification, quantification and iodination Rat GDNF used for iodination was produced and purified from baculovirus-infected Sf21 insect cells as described previously . Iodination was performed by the chloramine-T method to an average specific activity of 5 ϫ 10 7 c.p.m./µg. Iodinated GDNF was purified by size-exclusion chromatography through a Sephadex G25 column. Mutant GDNFs were produced in the conditioned medium of COS cells transiently transfected using the DEAE-dextran-chloroquine method. One day after transfection, complete medium was changed to serum-free Dulbecco's modified Eagle's medium (DMEM) supplemented with 5 µg/ml each of insulin and transferrin. Three days after this change, conditioned medium was harvested and concentrated 50-to 80-fold by ultrafiltration through Centriprep 10 cartridges (Amicon). The amount of GDNF present in the conditioned medium was quantified by Western blotting against standards of purified recombinant GDNF produced in insect cells (see above) or from commercial sources (PeProtech). Special care was taken to utilize anti-GDNF antisera that were raised against peptides from a region outside the mutations under study. Western blots were developed by enhanced chemifluorescence (ECF, Amersham), analysed in a STORM 840 fluorimager and quantified with ImageQuant software (Molecular Dynamics). Two mutants were purified from COScell-conditioned medium, K81A ϩ K84A and Y120A. Five hundred millilitres of COS-cell-conditioned medium, processed as above, were filtered and purified by subsequent steps of ion-exchange, size-exclusion and reverse-phase chromatography using Poros columns in a Biocad Sprint workstation (PerSeptive Biosystems).
Binding and c-Ret phosphorylation assays
For steady-state competitive binding assays, cells were plated in 96-well plates and exposed to 10 ng/ml 125 I-GDNF (~4 ϫ 10 -10 M) in phosphatebuffered saline (PBS) supplemented with 1 mg/ml bovine serum albumin (BSA), 1 mM MgCl 2 and 0.5 mM CaCl 2 , in the presence or absence of serial dilutions of unlabelled competitors. Binding was allowed to occur with gentle rocking at 4°C for at least 4 h, followed by three washes with ice-cold PBS and the addition of scintillation cocktail. Plates were then read in a MicroBeta gamma counter (Wallac). Background binding was determined using a 200-fold excess of unlabelled GDNF. For chemical cross-linking, the same procedure was followed except that cells were plated in 12-well plates. After 4 h at 4°C, cross-linking was started by the addition of 0.5 mM Bis-(sulfosuccinimidyl) suberate (BS 3 ). Cross-linking was allowed to proceed for 30 min at room temperature and stopped by the addition of 50 mM glycine in PBS. Wells were washed three times with PBS and then lysed with NP-40 lysis buffer as described previously (Trupp et al., 1998) . After SDS-PAGE, gels were fixed, dried, exposed to phosphorscreens (KODAK/ Molecular Dynamics) and analysed in a STORM 840 phosphorimager. Bands were quantified using ImageQuant software (Molecular Dynamics). c-Ret phosphorylation assays were performed as described previously (Trupp et al., 1998 (Trupp et al., , 1999 using ECF and fluorimaging detection as above. c-Ret phosphorylation was quantified using ImageQuant software. Levels of c-Ret phosphorylation were normalized to the total amount of c-Ret in each lane, quantified as above after reprobing of the polyvinylidenefluoride membranes with anti-c-Ret antibodies. For PIPLC treatments, cell monolayers were washed in serum-free medium and then incubated with 1 U/ml PIPLC (Sigma) in DMEM for 60 min at 37°C, followed by phosphorylation assay as described.
